SCHEMBL6188617

SCHEMBL6188617

CCOC(=O)C(C)c1ccc(-c2ccccc2F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 7/20 0.50
NPSR1 Q6W5P4 1/20 0.49
PTGS1 P23219 4/20 0.47
PGR P06401 1/20 0.47
PDE4A P27815 1/20 0.47
MEN1 O00255 2/20 0.47
PTGS2 P35354 2/20 0.47
KMT2A Q03164 2/20 0.47
MAPT P10636 2/20 0.47
FABP2 P12104 1/20 0.47
TSHR P16473 1/20 0.47
AKR1C4 P17516 1/20 0.47
ADRA2B P18089 1/20 0.47
CHRM3 P20309 1/20 0.47
HTR2C P28335 1/20 0.47
DRD3 P35462 1/20 0.47
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
AKR1C1 Q04828 1/20 0.47
SLC22A6 Q4U2R8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11837748 0.86 MAPT (0.49) GRIA4NPSR1PTGS1MEN1PTGS2
SCHEMBL11728161 0.86 GRIA4 (0.50) GRIA4NPSR1PTGS1MEN1PTGS2
SCHEMBL10705388 0.85 MAOB (0.53) GRIA4NPSR1PTGS1PGRPDE4A
SCHEMBL11849305 0.84 GRIA4 (0.46) GRIA4NPSR1PTGS1PGRPDE4A
Hydrochloric Acid SCHEMBL27850093 0.84 MAOB (0.52) GRIA4NPSR1PTGS1PGRPDE4A
SCHEMBL27915165 0.84 TSHR (0.43) PTGS2TSHRLMNAHPGDALDH1A1
SCHEMBL8755060 0.83 PTGS2 (0.70) NPSR1PTGS1PGRPDE4AMEN1
SCHEMBL17918662 0.83 PTGS2 (0.70) NPSR1PTGS1PGRPDE4AMEN1
SCHEMBL31456322 0.83 PTGS2 (0.70) NPSR1PTGS1PGRPDE4AMEN1
SCHEMBL9555720 0.83 PTGS2 (0.70) NPSR1PTGS1PGRPDE4AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979226-B1 ISOXAZOLE DERIVATIVES SUMITOMO PHARMA (JP) 2005-11-09 EP disclosed
US-6100260-A ((3-(1-(2-FLUORO-BIPHENYL-4-YL)-ETHYL)-ISOXAZOL-5-YLIMINO) -MORPHOLIN-4-YL-M ETHYL)-AMINE, FOR EXAMPLE; ADMINISTERING TO TREAT AUTOIMMUNE DISEASES AND INFLAMMATION SUMITOMO PHARMACEUTICAL COMPANY, LIMITED (JP) 2000-08-08 US disclosed